speb/financial-data huggingface dataset:
SLE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -15489000.00
SLE cash_flow (annual, 2023-12-31) — Change In Account Payable: 3412000.00
SLE cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -1244000.00
SLE cash_flow (annual, 2023-12-31) — Change In Interest Payable: -180000.00
SLE cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -85000.00
SLE cash_flow (annual, 2023-12-31) — Change In Payable: 3412000.00
SLE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2168000.00
SLE cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 146000.00
SLE cash_flow (annual, 2023-12-31) — Change In Receivables: -2113000.00
SLE cash_flow (annual, 2023-12-31) — Change In Working Capital: 116000.00
SLE cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2113000.00
SLE cash_flow (annual, 2023-12-31) — Changes In Cash: 5127000.00
SLE balance_sheet (annual, 2023-12-31) — Common Stock: 81000.00
SLE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 9990000.00
SLE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1885000.00
SLE income_statement (annual, 2023-12-31) — Cost Of Revenue: 15297000.00
SLE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1812000.00
SLE balance_sheet (annual, 2023-12-31) — Current Assets: 16758000.00
SLE balance_sheet (annual, 2023-12-31) — Current Debt: 800000.00
SLE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 800000.00
SLE balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 339000.00
SLE balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 339000.00
SLE balance_sheet (annual, 2023-12-31) — Current Liabilities: 13371000.00
SLE balance_sheet (annual, 2023-12-31) — Current Notes Payable: 0.00
SLE cash_flow (annual, 2023-12-31) — Depreciation: 85000.00
SLE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5376000.00
SLE income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 866000.00
SLE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5376000.00
SLE income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 866000.00
SLE balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 1571000.00
SLE income_statement (annual, 2023-12-31) — Diluted Average Shares: 5831.00
SLE income_statement (annual, 2023-12-31) — Diluted EPS: -6563.37
SLE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -38271000.00
SLE income_statement (annual, 2023-12-31) — EBIT: -30593000.00
SLE income_statement (annual, 2023-12-31) — EBITDA: -25217000.00
SLE cash_flow (annual, 2023-12-31) — End Cash Position: 7609000.00
SLE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 21441000.00
SLE cash_flow (annual, 2023-12-31) — Free Cash Flow: -16164000.00
SLE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -2217000.00
SLE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 2284000.00
SLE income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -2284000.00
SLE income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 2217000.00
SLE income_statement (annual, 2023-12-31) — General And Administrative Expense: 9392000.00
SLE balance_sheet (annual, 2023-12-31) — Goodwill: 1864000.00
SLE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 8500000.00
SLE balance_sheet (annual, 2023-12-31) — Gross PPE: 3678000.00
SLE income_statement (annual, 2023-12-31) — Gross Profit: 9782000.00
SLE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 7052000.00
SLE income_statement (annual, 2023-12-31) — Interest Expense: 50000.00
SLE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 50000.00
SLE balance_sheet (annual, 2023-12-31) — Invested Capital: 10790000.00
SLE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -825000.00
SLE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 21180000.00
SLE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
SLE balance_sheet (annual, 2023-12-31) — Line Of Credit: 800000.00
SLE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
SLE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3678000.00
SLE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -150000.00
SLE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 1885000.00
SLE income_statement (annual, 2023-12-31) — Net Income: -30330000.00
SLE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -38271000.00
SLE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -30330000.00
SLE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -30330000.00
SLE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -30330000.00
SLE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -30330000.00
SLE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -30330000.00
SLE cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -17000.00
SLE income_statement (annual, 2023-12-31) — Net Interest Income: -50000.00
SLE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -539000.00
SLE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
SLE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -50000.00
SLE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 800000.00
SLE balance_sheet (annual, 2023-12-31) — Net PPE: 70000.00
SLE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -8000.00
SLE cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 19295000.00
SLE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -539000.00
SLE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1490000.00
SLE balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 396000.00
SLE balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
SLE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
SLE income_statement (annual, 2023-12-31) — Normalized EBITDA: -17023000.00
SLE income_statement (annual, 2023-12-31) — Normalized Income: -22217940.00
SLE cash_flow (annual, 2023-12-31) — Operating Cash Flow: -15489000.00
SLE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 67000.00
SLE income_statement (annual, 2023-12-31) — Operating Income: -22426000.00
SLE income_statement (annual, 2023-12-31) — Operating Revenue: 25079000.00
SLE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 9946.00
SLE balance_sheet (annual, 2023-12-31) — Other Current Assets: 862000.00
SLE income_statement (annual, 2023-12-31) — Other Gand A: 5149000.00
SLE income_statement (annual, 2023-12-31) — Other Income Expense: -8167000.00
SLE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6636000.00
SLE cash_flow (annual, 2023-12-31) — Other Non Cash Items: -505000.00
SLE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 27000.00
SLE balance_sheet (annual, 2023-12-31) — Payables: 10420000.00
SLE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 12232000.00
SLE balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
SLE income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 7941000.00
SLE cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 19295000.00
SLE income_statement (annual, 2023-12-31) — Pretax Income: -30643000.00
SLE cash_flow (annual, 2023-12-31) — Purchase Of Business: -150000.00
SLE cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -17000.00
SLE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -8000.00
SLE balance_sheet (annual, 2023-12-31) — Receivables: 8287000.00
SLE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 10787000.00
SLE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 5376000.00
SLE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -539000.00
SLE income_statement (annual, 2023-12-31) — Research And Development: 9500000.00
SLE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1075000.00
SLE balance_sheet (annual, 2023-12-31) — Retained Earnings: -249014000.00
SLE income_statement (annual, 2023-12-31) — Salaries And Wages: 4243000.00
SLE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 12450000.00
SLE income_statement (annual, 2023-12-31) — Selling General And Administration: 21842000.00
SLE balance_sheet (annual, 2023-12-31) — Share Issued: 9946.00
SLE cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
SLE cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -539000.00
SLE income_statement (annual, 2023-12-31) — Special Income Charges: -10411000.00
SLE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2735000.00
SLE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 9990000.00
SLE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1490000.00
SLE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -81940.00
SLE income_statement (annual, 2023-12-31) — Tax Provision: -313000.00
SLE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.01
SLE balance_sheet (annual, 2023-12-31) — Total Assets: 25328000.00
SLE balance_sheet (annual, 2023-12-31) — Total Capitalization: 9990000.00
SLE balance_sheet (annual, 2023-12-31) — Total Debt: 800000.00
SLE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 9990000.00
SLE income_statement (annual, 2023-12-31) — Total Expenses: 47505000.00
SLE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 15338000.00
SLE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 8570000.00
SLE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1967000.00
SLE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -32837000.00
SLE income_statement (annual, 2023-12-31) — Total Unusual Items: -8194000.00
SLE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -8194000.00
SLE balance_sheet (annual, 2023-12-31) — Working Capital: 3387000.00
SLE balance_sheet (quarterly, 2024-09-30) — Current Debt: 1765000.00
SLE balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1765000.00
SLE cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
SLE balance_sheet (quarterly, 2024-09-30) — Net Debt: 1476000.00
SLE cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -23000.00
SLE cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 1084000.00
SLE balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 395000.00
SLE balance_sheet (quarterly, 2024-09-30) — Non Current Accrued Expenses: 0.00
SLE income_statement (quarterly, 2024-09-30) — Other Special Charges: 336000.00
SLE income_statement (quarterly, 2024-09-30) — Preferred Stock Dividends: 1694000.00
SLE cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 1084000.00
SLE cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
SLE cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -23000.00
SLE balance_sheet (quarterly, 2024-09-30) — Total Debt: 1765000.00
SLE income_statement (annual, 2024-12-31) — +Operating Expense: 23000000.00
SLE income_statement (annual, 2024-12-31) — +Total Revenue: 16182000.00
SLE balance_sheet (annual, 2024-12-31) — Accounts Payable: 5282000.00
SLE balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 5282000.00
SLE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3766000.00
SLE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3678000.00
SLE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -3678000.00
SLE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 270111000.00
SLE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
SLE income_statement (annual, 2024-12-31) — Basic Average Shares: 18625.00
SLE income_statement (annual, 2024-12-31) — Basic EPS: -1118.40
SLE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 7609000.00
SLE cash_flow (annual, 2024-12-31) — Capital Expenditure: -475000.00
SLE cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -452000.00
SLE balance_sheet (annual, 2024-12-31) — Capital Stock: 94000.00
SLE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1310000.00
SLE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1310000.00
SLE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5446000.00
SLE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -283000.00
SLE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -11462000.00
SLE cash_flow (annual, 2024-12-31) — Change In Account Payable: -3960000.00
SLE cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 110000.00
SLE cash_flow (annual, 2024-12-31) — Change In Interest Payable: 130000.00
SLE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -128000.00
SLE cash_flow (annual, 2024-12-31) — Change In Payable: -3960000.00
SLE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -3850000.00
SLE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 821000.00
SLE cash_flow (annual, 2024-12-31) — Change In Receivables: 4521000.00
SLE cash_flow (annual, 2024-12-31) — Change In Working Capital: 1364000.00
SLE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 4521000.00
SLE cash_flow (annual, 2024-12-31) — Changes In Cash: -6299000.00
SLE balance_sheet (annual, 2024-12-31) — Common Stock: 94000.00
SLE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 170000.00
SLE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1000000.00
SLE income_statement (annual, 2024-12-31) — Cost Of Revenue: 10080000.00
SLE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 138000.00
SLE balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 138000.00
SLE balance_sheet (annual, 2024-12-31) — Current Assets: 5753000.00
SLE balance_sheet (annual, 2024-12-31) — Current Debt: 4975000.00
SLE balance_sheet (quarterly, 2024-12-31) — Current Debt: 4975000.00
SLE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4975000.00
SLE balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 4975000.00
SLE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 50000.00
SLE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 50000.00
SLE balance_sheet (annual, 2024-12-31) — Current Liabilities: 10445000.00
SLE balance_sheet (annual, 2024-12-31) — Current Notes Payable: 4951000.00
SLE balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 4951000.00
SLE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2612000.00
SLE income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 770000.00
SLE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2612000.00
SLE income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 770000.00
SLE balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 935000.00
SLE income_statement (annual, 2024-12-31) — Diluted Average Shares: 18625.00
SLE income_statement (annual, 2024-12-31) — Diluted EPS: -1118.40
SLE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -21021000.00
SLE income_statement (annual, 2024-12-31) — EBIT: -15915000.00
SLE income_statement (annual, 2024-12-31) — EBITDA: -13303000.00
SLE cash_flow (annual, 2024-12-31) — End Cash Position: 1310000.00
SLE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5446000.00
SLE cash_flow (annual, 2024-12-31) — Free Cash Flow: -11937000.00
SLE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1115000.00
SLE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -183000.00
SLE cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -39000.00
SLE income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 183000.00
SLE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1115000.00
SLE income_statement (annual, 2024-12-31) — General And Administrative Expense: 7961000.00
SLE balance_sheet (annual, 2024-12-31) — Goodwill: 1864000.00
SLE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5934000.00
SLE balance_sheet (annual, 2024-12-31) — Gross PPE: 3702000.00
SLE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 3702000.00
SLE income_statement (annual, 2024-12-31) — Gross Profit: 6102000.00
SLE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
SLE income_statement (annual, 2024-12-31) — Interest Expense: 559000.00
SLE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 559000.00
SLE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 295000.00
SLE balance_sheet (annual, 2024-12-31) — Invested Capital: 5145000.00
SLE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -283000.00
SLE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 3393000.00
SLE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3257000.00
SLE balance_sheet (annual, 2024-12-31) — Line Of Credit: 24000.00
SLE balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 24000.00
SLE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3702000.00
SLE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 3702000.00
SLE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 192000.00
SLE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1000000.00
SLE balance_sheet (annual, 2024-12-31) — Net Debt: 3665000.00
SLE balance_sheet (quarterly, 2024-12-31) — Net Debt: 3665000.00
SLE income_statement (annual, 2024-12-31) — Net Income: -16635000.00
SLE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -21021000.00
SLE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16635000.00
SLE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16635000.00
SLE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16635000.00
SLE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -16635000.00
SLE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -16635000.00
SLE cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
SLE income_statement (annual, 2024-12-31) — Net Interest Income: -559000.00
SLE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 192000.00
SLE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 2861000.00
SLE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -559000.00
SLE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -808000.00
SLE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 1057000.00
SLE balance_sheet (annual, 2024-12-31) — Net PPE: 24000.00
SLE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -23000.00
SLE cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
SLE cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 2393000.00
SLE cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 264000.00
SLE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 2861000.00
SLE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -5764000.00
SLE balance_sheet (annual, 2024-12-31) — Non Current Accrued Expenses: 0.00
SLE balance_sheet (quarterly, 2024-12-31) — Non Current Accrued Expenses: 0.00
SLE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 161000.00
SLE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 161000.00
SLE income_statement (annual, 2024-12-31) — Normalized EBITDA: -14409000.00
SLE income_statement (annual, 2024-12-31) — Normalized Income: -17508740.00
SLE cash_flow (annual, 2024-12-31) — Operating Cash Flow: -11462000.00
SLE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1298000.00
SLE income_statement (annual, 2024-12-31) — Operating Income: -16898000.00
SLE income_statement (annual, 2024-12-31) — Operating Revenue: 16182000.00
SLE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 33800.00
SLE balance_sheet (annual, 2024-12-31) — Other Current Assets: 677000.00
SLE income_statement (annual, 2024-12-31) — Other Gand A: 5385000.00
SLE income_statement (annual, 2024-12-31) — Other Income Expense: 983000.00
SLE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 4070000.00
SLE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1206000.00
SLE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -123000.00
SLE balance_sheet (annual, 2024-12-31) — Payables: 5282000.00
SLE balance_sheet (quarterly, 2024-12-31) — Payables: 5282000.00
SLE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5420000.00
SLE balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
SLE income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 4386000.00
SLE cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 2393000.00
SLE cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 264000.00
SLE income_statement (annual, 2024-12-31) — Pretax Income: -16474000.00
SLE cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
SLE cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
SLE cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
SLE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -23000.00
SLE cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
SLE balance_sheet (annual, 2024-12-31) — Receivables: 3766000.00
SLE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 8238000.00
SLE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2612000.00
SLE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -396000.00
SLE income_statement (annual, 2024-12-31) — Research And Development: 4447000.00
SLE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 192000.00
SLE balance_sheet (annual, 2024-12-31) — Retained Earnings: -270035000.00
SLE income_statement (annual, 2024-12-31) — Salaries And Wages: 2576000.00
SLE cash_flow (annual, 2024-12-31) — Sale Of Business: 192000.00
SLE cash_flow (annual, 2024-12-31) — Sale Of Investment: 192000.00
SLE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 9822000.00
SLE income_statement (annual, 2024-12-31) — Selling General And Administration: 17783000.00
SLE balance_sheet (annual, 2024-12-31) — Share Issued: 33800.00
SLE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 3257000.00
SLE cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -396000.00
SLE income_statement (annual, 2024-12-31) — Special Income Charges: -9000.00
SLE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1289000.00
SLE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 170000.00
SLE balance_sheet (annual, 2024-12-31) — Tangible Book Value: -5764000.00
SLE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 232260.00
SLE income_statement (annual, 2024-12-31) — Tax Provision: 161000.00
SLE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
SLE balance_sheet (annual, 2024-12-31) — Total Assets: 11711000.00
SLE balance_sheet (annual, 2024-12-31) — Total Capitalization: 170000.00
SLE balance_sheet (annual, 2024-12-31) — Total Debt: 4975000.00
SLE balance_sheet (quarterly, 2024-12-31) — Total Debt: 4975000.00
SLE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 170000.00
SLE income_statement (annual, 2024-12-31) — Total Expenses: 33080000.00
SLE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 11541000.00
SLE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 5958000.00
SLE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1096000.00
SLE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -16754000.00
SLE income_statement (annual, 2024-12-31) — Total Unusual Items: 1106000.00
SLE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1106000.00
SLE balance_sheet (annual, 2024-12-31) — Working Capital: -4692000.00
SLE income_statement (quarterly, 2025-03-31) — +Operating Expense: 4841000.00
SLE income_statement (quarterly, 2025-03-31) — +Total Revenue: 2718000.00
SLE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5373000.00
SLE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2568000.00
SLE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 270710000.00
SLE income_statement (quarterly, 2025-03-31) — Amortization: 176000.00
SLE income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 176000.00
SLE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 35321.00
SLE income_statement (quarterly, 2025-03-31) — Basic EPS: -119.79
SLE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1310000.00
SLE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -100000.00
SLE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -100000.00
SLE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 95000.00
SLE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 747000.00
SLE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 747000.00
SLE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1357000.00
SLE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 283000.00
SLE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2203000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 107000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 184000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: 184000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 583000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Payable: 107000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 291000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -352000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1198000.00
SLE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1720000.00
SLE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1198000.00
SLE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -563000.00
SLE balance_sheet (quarterly, 2025-03-31) — Common Stock: 95000.00
SLE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -3461000.00
SLE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 231000.00
SLE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1522000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 124000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Assets: 4273000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Debt: 6735000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6735000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 633000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 633000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 12865000.00
SLE balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 6589000.00
SLE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 547000.00
SLE income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 315000.00
SLE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 547000.00
SLE income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 315000.00
SLE income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 139000.00
SLE balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 219000.00
SLE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 35321.00
SLE income_statement (quarterly, 2025-03-31) — Diluted EPS: -119.79
SLE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4231000.00
SLE income_statement (quarterly, 2025-03-31) — EBIT: -2828000.00
SLE income_statement (quarterly, 2025-03-31) — EBITDA: -2281000.00
SLE cash_flow (quarterly, 2025-03-31) — End Cash Position: 747000.00
SLE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1357000.00
SLE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2303000.00
SLE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -717000.00
SLE cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -243000.00
SLE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 243000.00
SLE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 717000.00
SLE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1381000.00
SLE balance_sheet (quarterly, 2025-03-31) — Goodwill: 1864000.00
SLE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5493000.00
SLE income_statement (quarterly, 2025-03-31) — Gross Profit: 1196000.00
SLE income_statement (quarterly, 2025-03-31) — Interest Expense: 1402000.00
SLE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1402000.00
SLE income_statement (quarterly, 2025-03-31) — Interest Income: 0.00
SLE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 0.00
SLE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 801000.00
SLE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3274000.00
SLE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 283000.00
SLE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 231000.00
SLE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 3079000.00
SLE balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 146000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 383000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 231000.00
SLE balance_sheet (quarterly, 2025-03-31) — Net Debt: 5988000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income: -4230000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4231000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -4230000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -4230000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -4230000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -4230000.00
SLE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -4230000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
SLE income_statement (quarterly, 2025-03-31) — Net Interest Income: -1402000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
SLE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1004000.00
SLE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1402000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 122000.00
SLE balance_sheet (quarterly, 2025-03-31) — Net PPE: 18000.00
SLE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 1004000.00
SLE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -8954000.00
SLE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 161000.00
SLE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 161000.00
SLE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3255000.00
SLE income_statement (quarterly, 2025-03-31) — Normalized Income: -5204000.00
SLE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2203000.00
SLE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -960000.00
SLE income_statement (quarterly, 2025-03-31) — Operating Income: -3645000.00
SLE income_statement (quarterly, 2025-03-31) — Operating Revenue: 2718000.00
SLE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 37144.00
SLE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 958000.00
SLE income_statement (quarterly, 2025-03-31) — Other Gand A: 730000.00
SLE income_statement (quarterly, 2025-03-31) — Other Income Expense: 817000.00
SLE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 3629000.00
SLE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 436000.00
SLE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -157000.00
SLE balance_sheet (quarterly, 2025-03-31) — Payables: 5373000.00
SLE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 5497000.00
SLE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
SLE income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 1000.00
SLE income_statement (quarterly, 2025-03-31) — Pretax Income: -4230000.00
SLE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
SLE cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
SLE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
SLE balance_sheet (quarterly, 2025-03-31) — Receivables: 2568000.00
SLE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1290000.00
SLE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 547000.00
SLE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2075000.00
SLE income_statement (quarterly, 2025-03-31) — Research And Development: 929000.00
SLE income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: -14000.00
SLE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -274266000.00
SLE income_statement (quarterly, 2025-03-31) — Salaries And Wages: 651000.00
SLE cash_flow (quarterly, 2025-03-31) — Sale Of Business: 383000.00
SLE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
SLE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2216000.00
SLE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3597000.00
SLE balance_sheet (quarterly, 2025-03-31) — Share Issued: 37144.00
SLE cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 3079000.00
SLE cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -2075000.00
SLE income_statement (quarterly, 2025-03-31) — Special Income Charges: 257000.00
SLE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 284000.00
SLE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -3461000.00
SLE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -8954000.00
SLE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SLE income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
SLE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Assets: 9784000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -3461000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Debt: 6735000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -3461000.00
SLE income_statement (quarterly, 2025-03-31) — Total Expenses: 6363000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 13245000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5511000.00
SLE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 380000.00
SLE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3631000.00
SLE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 974000.00
SLE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 974000.00
SLE balance_sheet (quarterly, 2025-03-31) — Working Capital: -8592000.00
SLE income_statement (quarterly, 2025-06-30) — +Operating Expense: 4454000.00
SLE income_statement (quarterly, 2025-06-30) — +Total Revenue: 3001000.00
SLE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5461000.00
SLE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2337000.00
SLE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 272954000.00
SLE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 53156.00
SLE income_statement (quarterly, 2025-06-30) — Basic EPS: -54.24
SLE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 747000.00
SLE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -110000.00
SLE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -100000.00
SLE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 78000.00
SLE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 475000.00
SLE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 475000.00
SLE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1007000.00
SLE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 513000.00
SLE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1792000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -4000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -92000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: -92000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 403000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Payable: -4000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -96000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 278000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -425000.00
SLE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 160000.00
SLE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -425000.00
SLE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -272000.00
SLE balance_sheet (quarterly, 2025-06-30) — Common Stock: 78000.00
SLE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -4117000.00
SLE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1714000.00
SLE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1692000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 116000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Assets: 3734000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Debt: 5730000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5730000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1036000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1036000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 12343000.00
SLE balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 5730000.00
SLE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 544000.00
SLE income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 131000.00
SLE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 544000.00
SLE income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 131000.00
SLE balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 74000.00
SLE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 53156.00
SLE income_statement (quarterly, 2025-06-30) — Diluted EPS: -54.24
SLE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — EBIT: -3145000.00
SLE income_statement (quarterly, 2025-06-30) — EBITDA: -2601000.00
SLE cash_flow (quarterly, 2025-06-30) — End Cash Position: 475000.00
SLE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1007000.00
SLE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1902000.00
SLE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -144000.00
SLE cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 91000.00
SLE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 100000.00
SLE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 144000.00
SLE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1522000.00
SLE balance_sheet (quarterly, 2025-06-30) — Goodwill: 1864000.00
SLE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 4713000.00
SLE income_statement (quarterly, 2025-06-30) — Gross Profit: 1309000.00
SLE income_statement (quarterly, 2025-06-30) — Interest Expense: -181000.00
SLE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: -181000.00
SLE income_statement (quarterly, 2025-06-30) — Interest Income: 181000.00
SLE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 181000.00
SLE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1613000.00
SLE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 513000.00
SLE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1714000.00
SLE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 932000.00
SLE balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
SLE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 623000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1714000.00
SLE balance_sheet (quarterly, 2025-06-30) — Net Debt: 5255000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2783000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2783000.00
SLE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2783000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -10000.00
SLE income_statement (quarterly, 2025-06-30) — Net Interest Income: 181000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -511000.00
SLE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 181000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -196000.00
SLE balance_sheet (quarterly, 2025-06-30) — Net PPE: 14000.00
SLE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -511000.00
SLE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -8830000.00
SLE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 161000.00
SLE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 161000.00
SLE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2845000.00
SLE income_statement (quarterly, 2025-06-30) — Normalized Income: -3027000.00
SLE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1792000.00
SLE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -53000.00
SLE income_statement (quarterly, 2025-06-30) — Operating Income: -3145000.00
SLE income_statement (quarterly, 2025-06-30) — Operating Revenue: 3001000.00
SLE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 73724.00
SLE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 922000.00
SLE income_statement (quarterly, 2025-06-30) — Other Gand A: 808000.00
SLE income_statement (quarterly, 2025-06-30) — Other Income Expense: 181000.00
SLE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2849000.00
SLE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -135000.00
SLE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -63000.00
SLE balance_sheet (quarterly, 2025-06-30) — Payables: 5461000.00
SLE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5577000.00
SLE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
SLE income_statement (quarterly, 2025-06-30) — Pretax Income: -2783000.00
SLE cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -10000.00
SLE balance_sheet (quarterly, 2025-06-30) — Receivables: 2337000.00
SLE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1279000.00
SLE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 544000.00
SLE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1443000.00
SLE income_statement (quarterly, 2025-06-30) — Research And Development: 694000.00
SLE income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
SLE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -277149000.00
SLE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 714000.00
SLE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 623000.00
SLE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2107000.00
SLE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3629000.00
SLE balance_sheet (quarterly, 2025-06-30) — Share Issued: 73724.00
SLE cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 932000.00
SLE cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -1443000.00
SLE income_statement (quarterly, 2025-06-30) — Special Income Charges: 100000.00
SLE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 475000.00
SLE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -4117000.00
SLE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -8830000.00
SLE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SLE income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
SLE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Assets: 8461000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -4117000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Debt: 5730000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -4117000.00
SLE income_statement (quarterly, 2025-06-30) — Total Expenses: 6146000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12578000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4727000.00
SLE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 235000.00
SLE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3145000.00
SLE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 244000.00
SLE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 244000.00
SLE balance_sheet (quarterly, 2025-06-30) — Working Capital: -8609000.00
SLE income_statement (quarterly, 2025-09-30) — +Operating Expense: 4131000.00
SLE income_statement (quarterly, 2025-09-30) — +Total Revenue: 2423000.00
SLE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5454000.00
SLE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1918000.00
SLE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 271518000.00
SLE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 90844.00
SLE income_statement (quarterly, 2025-09-30) — Basic EPS: 39.00
SLE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 475000.00
SLE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -25000.00
SLE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: 0.00
SLE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 82000.00
SLE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1061000.00
SLE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1061000.00
SLE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 3269000.00